Skip to main content

Peer Review reports

From: Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial

Original Submission
20 May 2024 Submitted Original manuscript
21 Jun 2024 Reviewed Reviewer Report - Emir Muzurović
8 Jul 2024 Reviewed Reviewer Report
9 Jul 2024 Reviewed Reviewer Report - Yong Jiang
7 Nov 2024 Author responded Author comments - Bong-Soo Cha
8 Dec 2024 Reviewed Reviewer Report
11 Feb 2025 Author responded Author comments - Bong-Soo Cha
Resubmission - Version 2
7 Nov 2024 Submitted Manuscript version 2
17 Mar 2025 Author responded Author comments - Bong-Soo Cha
Resubmission - Version 3
17 Mar 2025 Submitted Manuscript version 3
Publishing
18 Mar 2025 Editorially accepted
7 May 2025 Article published 10.1186/s12916-025-04017-x

You can find further information about peer review here.

Back to article page